Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994 Nov;23(6 Suppl):84-97.

An update on the malignant hyperthermia syndrome

H Rosenberg  1 , J E Fletcher
Affiliations
  • PMID: 7710242
Review

An update on the malignant hyperthermia syndrome

H Rosenberg et al. Ann Acad Med Singap. 1994 Nov.

Abstract

Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle. In humans, MH is inherited in an autosomal dominant fashion; in swine, the principal model for MH, it is in a recessive fashion. Those with MH susceptibility usually are asymptomatic except in the presence of certain "triggering" anaesthetic agents such as isoflurane, enflurane and the muscle relaxant succinylcholine. Upon such exposure hypermetabolism, increased CO2 production, acidosis, muscle rigidity, rhabdomyolysis and hyperthermia occur. Untreated, death may result in 70% of patients. With prompt diagnosis and treatment with dantrolene sodium, the mortality is less than 10%. The overall incidence of MH is low (perhaps 1:50,000 anaesthetics), but it is more common in children. Children also display a paradoxical increase in jaw muscle tone to succinylcholine which often presages MH, but confusing clinically, may also be a normal response to succinylcholine. The pathophysiology of MH centres around a defect in calcium flux in skeletal muscle. A specific base pair change in the gene that codes for the ryanodine receptor calcium channel in muscle has been demonstrated in susceptible swine, but occurs rarely in humans. It is hoped that the understanding of the molecular genetics of MH will lead to a simpler diagnostic test than is currently available, and enhance our understanding of MH and its relation to other myopathies.

PubMed Disclaimer

Similar articles

  • Malignant hyperthermia.
    Rosenberg H, Davis M, James D, Pollock N, Stowell K. Rosenberg H, et al. Orphanet J Rare Dis. 2007 Apr 24;2:21. doi: 10.1186/1750-1172-2-21. Orphanet J Rare Dis. 2007. PMID: 17456235 Free PMC article. Review.
  • Malignant hyperthermia.
    Ben Abraham R, Adnet P, Glauber V, Perel A. Ben Abraham R, et al. Postgrad Med J. 1998 Jan;74(867):11-7. doi: 10.1136/pgmj.74.867.11. Postgrad Med J. 1998. PMID: 9538480 Free PMC article. Review.
  • Malignant hyperthermia.
    Denborough M. Denborough M. Lancet. 1998 Oct 3;352(9134):1131-6. doi: 10.1016/S0140-6736(98)03078-5. Lancet. 1998. PMID: 9798607 Review.
  • Malignant hyperthermia.
    Halliday NJ. Halliday NJ. J Craniofac Surg. 2003 Sep;14(5):800-2. doi: 10.1097/00001665-200309000-00039. J Craniofac Surg. 2003. PMID: 14501352
  • [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
    Schuster F, Johannsen S. Schuster F, et al. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019 Sep;54(9):549-558. doi: 10.1055/a-0725-7577. Epub 2019 Sep 16. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019. PMID: 31525788 German.
See all similar articles

Cited by

See all "Cited by" articles